The demand for medication price transparency has reached a tipping point. Patients are expecting it, health insurance providers are adopting it, and the federal government is requiring it. In fact, a recent survey of U.S. patients revealed that patients believe prescription price transparency at the point of care helps them afford their medications (55%), and increases both their satisfaction with their doctor (50%) and the likelihood that they’ll stay with that health care provider (50%). Payers play an important role in accelerating the use of medication price transparency tools like Real-Time Prescription Benefit and Electronic Prior Authorization. There is a need to deepen the payer segments understanding of the regulations surrounding these tools, the impact these tools have on the providers workflow and how payer engagement drives adoption of these tools.
Dr. Andrew Mellin
Vice President and Chief Medical Information Officer
Andrew Mellin, MD, MBA, is VP, Chief Medical Information Officer at Surescripts, where he helps the Surescripts Network Alliance improve the care experience for both providers and patients with a focus on technology and smart workflow solutions. Dr. Mellin has over 20 years of experience in health information technology, patient quality and safety, consumer health and EHR implementation and adoption. He is Board Certified in Internal Medicine and worked as a part-time hospitalist in St. Paul, MN for 15 years.